Inventor

David T. Curiel

Inventor

Birmingham, AL, US

Overview

39→

Patents

1996–2020

Patent span

Chemistry

Primary field (CPC C)

Patents· 39 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes31%

C12NMicroorganisms or enzymes28%

C07KPeptides22%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations12%

Y10TTechnical subjects covered by former us classification3%

Y02ATechnologies for adaptation to climate change2%

PatentTitleYear

10,709,745Tropic cell based virotherapy for the treatment of cancer2020 10,391,183Infectivity-enhanced conditionally-replicative adenovirus and uses thereof2019 10,238,699Tropic cell based virotherapy for the treatment of cancer2019 9,267,153'Porcine knob xenotype chimeric adenoviral vector for dendritic cell infection'2016 7,297,542'Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob'2007 7,045,127'Human anti-epidermal growth factor receptor single-chain antibodies'2006 6,955,808'Capsid-modified recombinant adenovirus and methods of use'2005 6,841,540'Immunomodulation by genetic modification of dendritic cells and B cells'2005 6,824,771'Infectivity-enhanced conditionally-replicative adenovirus and uses thereof'2004 6,815,200'Modified adenovirus containing a fiber replacement protein'2004 6,716,622'Tissue-specific self-inactivating gene therapy vector'2004 6,716,823'Noninvasive genetic immunization, expression products therefrom, and uses thereof'2004 6,706,693'Vaccination by topical application of genetic vectors'2004 6,699,473'Human anti-epidermal growth factor receptor single-chain antibodies'2004 6,689,605'Controlling immune response to specific antigens'2004 6,683,170'Ligands added to adenovirus fiber'2004 6,649,396'Fiber receptor-independent system for the propagation of adenoviral vectors'2003 6,613,563'Viral vectors with modified tropism'2003 6,599,909'Molecular chemotherapy enhancement of radiotherapy'2003 6,555,368'Capsid-modified recombinant adenovirus and methods of use'2003 6,468,547'Enhancement of tumor cell chemosensitivity and radiosensitivity using single chain secretory antibodies'2002 6,436,393'Adenoviral vector encoding anti-apoptotic Bcl-2 gene and uses thereof'2002 6,348,450'Noninvasive genetic immunization, expression products therefrom and uses thereof'2002 6,333,030'Chimeric retrovirus/adenovirus system'2001 6,312,699'Ligands added to adenovirus fiber'2001 6,284,742'Immunomodulation by genetic modification of dendritic cells and B cells'2001 6,274,322'Composition for introducing nucleic acid complexes into higher eucaryotic cells'2001 6,210,946'Modified adenovirus containing a fiber replacement protein'2001 6,077,663'Composition for introducing nucleic acid complexes into higher eucaryotic cells'2000 6,074,640'Enhancement of tumor cell radiosensitivity using single chain intracellular antibodies'2000 6,028,059'Methods for modulating protein function in cells using intracellular antibody homologues'2000 6,022,735'Composition for introducing nucleic acid complexes into higher eucaryotic cells'2000 5,981,273'Composition comprising an endosomolytic agent for introducing nucleic acid complexes into higher eucaryotic cells'1999 5,981,504'Genetic induction of receptors for targeted radiotherapy'1999 5,910,486'Methods for modulating protein function in cells using, intracellular antibody homologues'1999 5,902,583'Genetic induction of receptors for targeted radiotherapy'1999 5,871,727'Targeted adenovirus vectors'1999 5,547,932'Composition for introducing nucleic acid complexes into higher eucaryotic cells'1996 5,521,291'Conjugates for introducing nucleic acid into higher eucaryotic cells'1996

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1996–2001Patents assigned to BOEHRINGER INGELHEIM INT (6)· patent assignee history

1996–2001Patents assigned to GENENTECH INC (6)· patent assignee history

1996–2001Patents assigned to UNIV NORTH CAROLINA (6)· patent assignee history

1996–2001Based in Chapel Hill, NC, US· patent location history

1999–2007Patents assigned to UAB RESEARCH FOUNDATION (28)· patent assignee history

1999–2007Based in Birmingham, AL, US· patent location history

2016–2020Based in St. Louis, MO, US· patent location history

2019–2020Patents assigned to HOPE CITY (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
UAB RESEARCH FOUNDATION	28	1999–2007
BOEHRINGER INGELHEIM INT	6	1996–2001
GENENTECH INC	6	1996–2001
UNIV NORTH CAROLINA	6	1996–2001
HOPE CITY	2	2019–2020

Locations

Location	Patents	Span
Birmingham, AL, US	29	1999–2007
Chapel Hill, NC, US	6	1996–2001
St. Louis, MO, US	4	2016–2020